Rowland Thomas Andrew 4
4 · VENTRUS BIOSCIENCES INC · Filed Jan 27, 2011
Insider Transaction Report
Form 4
Rowland Thomas Andrew
Director
Transactions
- Award
Stock Options (Right to Buy)
2011-01-25+250,000→ 250,000 totalExercise: $6.42Exp: 2021-01-25→ Common Stock (250,000 underlying)
Holdings
- 18,387
Common Stock
- 35,000
Stock Options (Right to Buy)
Exercise: $6.00Exp: 2020-11-10→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The options vested 1/3 on 1/25/2011, and the remaining 2/3 will vest in equal installments on the first, second and third anniversaries after 1/25/2011.
- [F2]The options vested 1/3 on 3/1/2009, and the remaining 2/3 will vest in equal installments on the first, second and third anniversaries after 3/1/2009.